Literature DB >> 17652789

Site-specific biotinylation of human myeloid differentiation protein 88 in Drosophila melanogaster Schneider 2 cell cytoplasm.

G Basile1, M Peticca, S Catello.   

Abstract

In this work we describe the production of site-specific biotinylated human myeloid differentiation factor 88 (MyD88). A vector containing a coding sequence for a peptide derived from the carboxyl terminus of the Klebsiella pneumoniae oxalacetate decarboxylase alpha subunit was used to allow expression and biotinylation of MyD88 in Drosophila melanogaster Schneider 2 cell cytoplasm. As estimated by a comparison of Schneider 2 lysate with standard protein, the maximum expression level was 1.3 mug 107 cells-1. About 4 mg of biotinylated protein was purified by affinity chromatography on monomeric avidin from a 1-L culture. Exogenous biotin added to the culture medium increased the biotinylation efficiency of the expressed protein. Biotinylated MyD88 produced in Drosophila cells was able to precipitate recombinant MyD88 expressed in human embryonic kidney cells. The stable expression of MyD88 in Drosophila Schneider 2 cells offers a convenient and attractive method for large-scale production, which may be required to clarify the role of MyD88 in the inflammatory response. Moreover, site-specific biotinylation of MyD88 provides a useful tag for interaction assays where high sensitivity is required.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17652789     DOI: 10.1007/bf02686011

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  29 in total

1.  In vivo biotinylation of the major histocompatibility complex (MHC) class II/peptide complex by coexpression of BirA enzyme for the generation of MHC class II/tetramers.

Authors:  Junbao Yang; Andrés Jaramillo; Ruili Shi; William W Kwok; T Mohanakumar
Journal:  Hum Immunol       Date:  2004-07       Impact factor: 2.850

2.  Complexity of the immediate early response of myeloid cells to terminal differentiation and growth arrest includes ICAM-1, Jun-B and histone variants.

Authors:  K A Lord; B Hoffman-Liebermann; D A Liebermann
Journal:  Oncogene       Date:  1990-03       Impact factor: 9.867

3.  Interaction of [fluorescein-Trp25]glucagon with the human glucagon receptor expressed in Drosophila Schneider 2 cells.

Authors:  M R Tota; L Xu; A Sirotina; C D Strader; M P Graziano
Journal:  J Biol Chem       Date:  1995-11-03       Impact factor: 5.157

4.  Expression of functional recombinant antibody molecules in insect cell expression systems.

Authors:  B Reavy; A Ziegler; J Diplexcito; S M Macintosh; L Torrance; M Mayo
Journal:  Protein Expr Purif       Date:  2000-03       Impact factor: 1.650

5.  Heat shock proteins are induced by cadmium in Drosophila cells.

Authors:  A M Courgeon; C Maisonhaute; M Best-Belpomme
Journal:  Exp Cell Res       Date:  1984-08       Impact factor: 3.905

6.  Regulated expression at high copy number allows production of a growth-inhibitory oncogene product in Drosophila Schneider cells.

Authors:  H Johansen; A van der Straten; R Sweet; E Otto; G Maroni; M Rosenberg
Journal:  Genes Dev       Date:  1989-06       Impact factor: 11.361

7.  Molecular characterization and modular analysis of human MyD88.

Authors:  G Hardiman; F L Rock; S Balasubramanian; R A Kastelein; J F Bazan
Journal:  Oncogene       Date:  1996-12-05       Impact factor: 9.867

8.  Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli.

Authors:  P J Schatz
Journal:  Biotechnology (N Y)       Date:  1993-10

9.  Stable expression of a functional homo-oligomeric Drosophila GABA receptor in a Drosophila cell line.

Authors:  N S Millar; S D Buckingham; D B Sattelle
Journal:  Proc Biol Sci       Date:  1994-12-22       Impact factor: 5.349

10.  Functional expression of a cloned Drosophila muscarinic acetylcholine receptor in a stable Drosophila cell line.

Authors:  N S Millar; H A Baylis; C Reaper; R Bunting; W T Mason; D B Sattelle
Journal:  J Exp Biol       Date:  1995-09       Impact factor: 3.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.